YOLFTbeta
Navamedic ASA

Navamedic ASA

NAVA · OL · Healthcare / Medical Distribution

10.80NOK+0.35 (+3.35%)

Price History

Full chart

Market Stats

Previous Close10.45
Open11.00
Day Range10.60 – 11.00
52-Week Range13.05 – 26.50
Volume24.30K
Market Cap312.96M
P/E (TTM)0.00
Forward P/E14.73
EPS-1.08
Dividend Yield0.00%
Beta0.24
50-Day Avg14.84
200-Day Avg18.47

About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases, fat metabolism, renal, nutritional support, and ketogenic diet. In addition, it provides consumer health products consisting of non-prescription drugs and health care products for erectile dysfunction, pain, gastro-related problems, and others primarily through pharmacies and drugstores; prescription medicines covering obesity, Parkinson's disease, urology, and cardiology; and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was founded in 2002 and is headquartered in Oslo, Norway.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Lars Minor
  • Employees38
  • HeadquartersHenrik Ibsens gate 100, Oslo, Norway, 0255, Norway
  • Websitehttps://navamedic.com

Leadership

  • Mr. Lars MinorChief Executive Officer · b. 1970
  • Mr. Nils Ole KreklingChief Financial Officer
  • Mr. Alexander LidmejerChief Operating Officer · b. 1981
  • Pal Zimmermann VonenDirector of Group Accounting
  • Ms. Astrid J. Torgersen BratvedtChief Scientific Officer
  • Annika PaloDirector of QA, Compliance & Sustainability
  • Mr. Ole Henrik EriksenChief Business Development Officer · b. 1960
  • Nina MasvaerCommercial Director of Nordics & Head of Rx

Financials

Income Statement

Currency: NOK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue87.00K1.17M4.43M386.45K31.84M46.11M52.59M55.09M71.30M88.68M151.77M223.07M248.35M274.30M257.92M184.02M188.75M209.88M278.44M382.13M512.00M531.44M565.36M
Growth (%)-+1245.05%+278.73%-91.28%+8137.91%+44.82%+14.07%+4.75%+29.42%+24.38%+71.14%+46.97%+11.33%+10.45%-5.97%-28.65%+2.57%+11.19%+32.67%+37.24%+33.98%+3.80%+6.38%
Cost of Revenue29.11K685.54K2.08M330.06K10.67M25.32M31.96M32.99M42.03M51.17M104.45M168.81M187.45M204.26M187.65M122.64M131.15M139.54M166.69M218.62M312.94M322.56M345.04M
Gross Profit57.89K484.65K2.36M56.39K21.16M20.78M20.63M22.10M29.27M37.52M47.32M54.26M60.90M70.04M70.27M61.39M57.60M70.34M111.74M163.52M199.05M208.88M220.32M
Gross Margin66.54%41.42%53.17%14.59%66.48%45.08%39.23%40.12%41.06%42.30%31.18%24.32%24.52%25.53%27.25%33.36%30.52%33.51%40.13%42.79%38.88%39.30%38.97%
Operating Expense403.60K4.20M7.93M11.18M26.07M22.08M30.63M37.23M38.63M41.74M45.17M47.09M64.72M84.60M80.85M65.96M67.69M75.26M106.89M112.76M175.47M184.75M203.22M
Operating Income-345.72K-3.71M-5.58M-11.12M-4.91M-1.30M-10.00M-15.13M-9.36M-4.23M2.16M7.16M-3.82M-14.57M-10.57M-4.57M-10.09M-4.92M4.86M50.76M23.58M24.13M17.10M
Operating Margin-397.38%-317.10%-125.81%-2878.54%-15.42%-2.82%-19.01%-27.46%-13.13%-4.77%1.42%3.21%-1.54%-5.31%-4.10%-2.48%-5.34%-2.35%1.75%13.28%4.61%4.54%3.02%
EBITDA-287.54K-3.46M-3.27M-9.67M4.13M9.86M-2.51M-8.76M-2.96M1.72M6.02M15.42M8.83M5.05M-2.48M15.51M-8.71M-10.23M16.68M54.27M37.09M46.55M30.25M
EBITDA Margin-330.50%-295.52%-73.71%-2503.13%12.96%21.38%-4.77%-15.90%-4.15%1.94%3.96%6.91%3.56%1.84%-0.96%8.43%-4.61%-4.88%5.99%14.20%7.25%8.76%5.35%
Net Income484.45K5.28M-4.87M-7.57M-3.21M-8.08M12.82M-11.19M-7.16M-3.25M-1.27M1.31M-10.93M-10.66M-15.54M7.28M-16.30M-16.46M618.00K29.43M3.30M1.29M-23.54M
Net Income Margin556.84%451.51%-109.81%-1959.38%-10.09%-17.52%24.37%-20.31%-10.04%-3.67%-0.84%0.59%-4.40%-3.89%-6.03%3.96%-8.63%-7.84%0.22%7.70%0.65%0.24%-4.16%
R&D-------484.00K---------------
R&D as % of Total Revenue-------0.88%---------------
Interest Expense47.32K63.87K00516.96K2.08M2.31M592.70K934.39K492.99K4.04M4.16M8.80M1.45M2.90M1.81M2.44M3.84M4.42M3.42M14.34M16.83M14.55M
Interest Expense % of Total Revenue54.39%5.46%0.00%0.00%1.62%4.52%4.40%1.08%1.31%0.56%2.66%1.87%3.54%0.53%1.12%0.98%1.29%1.83%1.59%0.89%2.80%3.17%2.57%

Balance Sheet

Currency: NOK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets770.79K17.09M47.99M52.42M185.46M159.65M136.55M123.33M139.07M133.75M179.48M213.20M275.55M287.67M247.27M214.73M187.06M260.04M330.18M382.77M524.30M491.24M741.75M
Total Liabilities-6.44M-1.94M4.81M-8.44M56.46M49.40M24.77M23.12M45.83M37.07M72.22M101.97M157.27M181.94M150.57M115.41M107.83M130.55M178.94M173.05M301.91M250.81M407.67M
Total Equity7.21M19.03M43.19M60.87M129.00M110.24M111.78M100.21M93.24M96.68M107.26M111.23M118.28M105.73M96.70M99.32M79.23M129.49M151.24M209.72M222.39M240.44M334.08M
Cash2.59M5.44M30.01M24.41M38.36M16.37M35.67M14.14M9.59M3.62M2.24M6.18M12.30M26.80M30.25M11.05M11.44M38.80M51.70M54.30M38.04M37.28M72.57M
Total Debt-----16.00M--10.19M-12.48M27.38M51.13M58.85M12.21M32.58M43.94M42.63M69.55M62.70M173.74M139.93M-
Net Debt---30.01M-24.41M-38.36M-373.68K-35.67M-14.14M10.19M-3.62M10.24M21.20M38.84M32.05M-18.04M21.53M32.50M3.84M16.27M8.40M135.70M102.65M152.25M

Cash Flow

Currency: NOK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.40M-3.62M-3.11M-10.74M5.56M-10.66M-1.65M-13.46M-95.52K-6.47M-15.65M-10.75M22.63M-14.51M59.07M-36.02M12.72M-3.18M-1.30M17.94M2.18M39.35M25.59M
Investing Cash Flow-2.06M-4.18M-5.00M-5.15M-50.03M-8.22M38.46M-1.42M-14.84M2.14M-2.25M-887.54K-24.32M-1.68M-7.00M-2.16M-1.87M-23.14M-727.00K-25.44M-104.58M-2.78M-186.65M
Financing Cash Flow9.04M10.66M32.69M10.29M58.43M-4.00M-16.00M-7.54M-9.10M13.37M15.40M8.35M31.91M-48.62M20.37M-10.90M51.76M15.93M10.07M83.23M-37.74M197.00M
Capital Expenditure1.77M3.35M5.16M4.76M1.43M875.99K16.87K1.71M13.91M02.25M887.54K782.82K1.68M7.06M2.16M721.41K4.99M728.00K2.25M2.20M3.32M2.38M
Free Cash Flow-6.17M-6.97M-8.27M-10.74M5.56M-11.54M-1.66M-15.18M-14.01M-6.47M-17.90M-11.64M21.85M-16.18M52.01M-38.19M12.00M-8.17M-2.03M15.69M-19.00K38.36M23.20M
Dividends Paid-------7.54M---------------
FCF to OCF140.28%192.57%265.56%100.00%100.00%108.22%101.02%112.73%14662.14%100.00%114.37%108.26%96.54%111.55%88.04%106.00%94.33%257.04%156.00%87.45%-0.87%97.47%90.69%
Dividend Paid to FCF--------49.66%---------------

Earnings

Report DateMar 31, 2006Jun 30, 2006Oct 25, 2006Feb 28, 2007May 30, 2007Aug 22, 2007Oct 24, 2007Feb 6, 2008Apr 23, 2008Aug 13, 2008Oct 22, 2008Feb 26, 2009Apr 28, 2009Aug 18, 2009Nov 18, 2009Feb 11, 2010May 5, 2010Aug 26, 2010Oct 27, 2010Feb 3, 2011May 4, 2011Aug 26, 2011Oct 20, 2011Feb 10, 2012May 3, 2012Aug 23, 2012Oct 23, 2012Feb 14, 2013Apr 25, 2013Aug 30, 2013Nov 1, 2013Feb 26, 2014May 6, 2014Aug 22, 2014Oct 31, 2014Feb 27, 2015Apr 28, 2015Aug 21, 2015Oct 30, 2015Feb 18, 2016May 11, 2016Aug 18, 2016Nov 11, 2016Feb 15, 2017May 10, 2017Jul 27, 2017Nov 10, 2017Feb 15, 2018May 30, 2018Aug 24, 2018Nov 9, 2018Feb 14, 2019May 15, 2019Aug 23, 2019Nov 1, 2019Feb 13, 2020May 14, 2020Aug 14, 2020Nov 6, 2020Feb 18, 2021May 11, 2021Aug 13, 2021Nov 4, 2021Feb 17, 2022Aug 12, 2022Nov 1, 2022Feb 16, 2023May 11, 2023Aug 10, 2023Nov 1, 2023Feb 15, 2024Jun 4, 2024Aug 16, 2024Sep 30, 2024Feb 12, 2025Apr 30, 2025Aug 14, 2025Oct 28, 2025Feb 12, 2026Apr 23, 2026Aug 14, 2026Oct 29, 2026
EPS Estimate---0.30---0.040.37-0.05-0.13--0.060.02-0.14-0.03-0.11-0.32-0.12-0.36-0.36------------------------------------------0.220.460.030.480.430.420.31-0.280.910.130.100.500.08-0.11-0.04-0.29-0.02-0.05
EPS Actual-0.43-0.32-0.29-0.27-0.40-0.210.28-0.21-0.01-0.300.53-0.85-0.14-0.61-0.400.76-0.22-0.32-0.34-0.46-0.24-0.22-0.27-0.21-0.12-0.05-0.17-0.040.16-0.06-0.11-0.140.000.050.17-0.070.150.09-0.24-1.13-0.43-1.34-0.110.71-0.240.05-0.21-0.51-0.660.02-0.141.44-0.45-0.38-0.383.58-0.790.04-0.02-0.33-0.220.20-0.120.080.430.031.170.770.150.39-0.02-0.091.15--1.14-0.42-0.09-0.15-0.46-0.00-0.12-
Surprise--3.33%---600.00%-156.76%80.00%-130.77%---333.33%-3150.00%-185.71%2633.33%-100.00%0.00%-183.33%-27.78%33.33%-------------------------------------------63.64%-6.52%0.00%143.75%78.26%-64.29%25.81%--132.14%26.37%--1242.10%-184.40%-212.50%-33.91%-1052.75%98.31%-500.00%-
Timing--Pre-market---Pre-marketPre-marketPre-marketPre-market--Pre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours---After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market-------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market--Pre-marketPre-marketPre-market--Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap312.96M
Enterprise Value450.20M
Trailing P/E0.00
Forward P/E14.73
PEG Ratio1.38
Price / Sales0.54
Price / Book1.05
EPS-1.08
Book Value12.76
Revenue (TTM)574.31M
Gross Profit (TTM)226.17M
EBITDA47.19M
Profit Margin-4.03%
Operating Margin1.10%
Return on Equity-8.86%
Return on Assets0.46%
Shares Outstanding23.98M
Shares Float9.98M
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20101×
0.76Apr 13, 2010

Stock Splits

  • Jul 15, 2025481:473
  • Feb 19, 2020663:662